Has Mohamed Elshazly, MD received payments from drug or device companies?

Yes. Drug and device makers reported $52,255 in general payments to Mohamed Elshazly, MD across 333 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mohamed Elshazly, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mohamed Elshazly, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mohamed Elshazly, MD

Clinical Cardiac Electrophysiology · Lake Mary, FLNPI 1710290721

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Cordis US CORP. at 29.5% of the total. 2025 is the largest year on record at $25,664, more than ten times the $129 reported in 2021.

$52,255in general payments, 2019–2025

Across 333 payments — averaging $156.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Cordis US CORP.$15K
Biotronik Inc.$12K
Abbott$8K
Novo Nordisk$5K
Medtronic$4K
Boston Scientific$3K
plus $6K from 14 others

$99,691in research payments, 2019–2025

Across 5 payments — averaging $19,938 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Cala Health, Inc.$100K

What the payments were for

Consulting fees$24,75047%
Travel & lodging$11,44322%
Food & beverage$15,90430%
Education$1570%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Cordis US CORP.	14	$15,408
Biotronik Inc.	52	$11,884
Abbott	56	$7,564
Novo Nordisk	3	$4,500
Medtronic	46	$3,600
Boston Scientific	53	$3,103
Biosense Webster, Inc.	50	$1,853
Medical Device Business Services, Inc.	1	$1,575
Philips North America LLC	12	$890
Cardiva Medical, Inc.	16	$499
Atricure, Inc.	14	$367
Vektor Medical Inc.	1	$365
Kestra Medical Technology Services, Inc.	2	$341
Irhythm Technologies, Inc.	2	$107
Cvrx, Inc.	2	$63
Novartis	2	$43
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	4	$34
Kiniksa Pharmaceuticals International, PLC	1	$22
Siemens Medical Solutions USA, Inc.	1	$20
AstraZeneca	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$52,255 in reported general payments places this provider in the 75th percentile of 249 clinical cardiac electrophysiology providers in Florida.

See all clinical cardiac electrophysiology providers in Florida →

Medicare billing

Part B allowed, 2024

$207,116

Medicare patients

738

Services billed

2,357

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	165	$177,115
XareltoRivaroxaban	38	$49,370
MultaqDronedarone Hcl	12	$15,683
Dabigatran EtexilateDabigatran Etexilate Mesylate	12	$4,995
Metoprolol Succinate	197	$2,976
Flecainide Acetate	31	$1,861
Amiodarone Hcl	47	$1,162
Diltiazem 24hr Er (Cd)Diltiazem Hcl	29	$943
Verapamil ErVerapamil Hcl	25	$565
Digoxin	24	$458
ClopidogrelClopidogrel Bisulfate	41	$445
Bisoprolol Fumarate	22	$408
SotalolSotalol Hcl	12	$348
Metoprolol Tartrate	25	$329
Atorvastatin Calcium	29	$325

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Lake Mary

Jorge DiazLake Mary$158K
Usman SiddiquiWinter Park$1.2M
Jose Osorio FilhoMiami$1.2M
David KenigsbergFort Lauderdale$1M
Raul WeissMiami Beach$887K
Naushad ShaikKissimmee$691K
Parikshit SharmaWeston$462K
Saumil OzaJacksonville$462K
Brian BetenskySarasota$412K
Antonio MorettaSarasota$312K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →